LawPlayer
My bookmarksSign up freeSign up free
Source

2010/180/: Commission Decision of 25 March 2010 on amending Decision 2008/911/EC establishing a list of herbal substances, preparations and combinations thereof for use in traditional herbal medicinal products (notified under document C(2010) 1867) (Text with EEA relevance)

2010/180/: Commission Decision of 25 March 2010 on amending Decision 2008/911/EC establishing a list of herbal substances, preparations and combinations thereof for use in traditional herbal medicinal products (notified under document C(2010) 1867) (Text with EEA relevance)

Decision 2008/911/EC · Decision · 3 articles

Data as of 2026-07-04 · Compiled from an official source version. Later amendments or repeals may not be reflected; the official text prevails. · Read the official text ↗

Article 1

Open ↗

Decision 2008/911/EC is amended as follows: 1. Articles 1 and 2 are replaced by the following: ‘Article 1 A list of herbal substances, preparations and combinations thereof for use in traditional herbal medicinal products is established in Annex I. Article 2 The indications, the specified strengths and the posology, the route of administration and any other information necessary for the safe use of the herbal substance as a traditional medicinal product relevant for the herbal substances listed in Annex I are set out in Annex II.’. 2. Annexes I and II are amended in accordance with the Annex to this Decision.

Supplementary provisions

ANNEXSupplementary provisions

Open ↗

ANNEX Annexes I and II to Decision 2008/911/EC are amended as follows: 1. in Annex I, the following substance is inserted after Foeniculum vulgare Miller subsp. vulgare var. dulce (Miller) Thellung (sweet fennel fruit): ‘ Mentha x piperita L.’; 2. in Annex II, the following is inserted after the entry relating to Foeniculum vulgare Miller subsp. vulgare var. dulce (Miller) Thellung, fructus: ‘ COMMUNITY LIST ENTRY ON MENTHA x PIPERITA L., AETHEROLEUM Scientific name of the plant Mentha x piperita L. Botanical family Lamiaceae (Labiatae) Herbal preparation(s) Peppermint oil : essential oil obtained by steam distillation from the fresh aerial parts of the flowering plant European Pharmacopoeia monograph reference Peppermint oil — Menthae piperitae aetheroleum (01/2008:0405) Indication(s) Herbal medicinal product traditionally used: 1. for the relief of symptoms in coughs and colds; 2. for the symptomatic relief of localised muscle pain; 3. for the symptomatic relief of localised pruritic conditions in intact skin. The product is a traditional herbal medicinal product for use in specified indications exclusively based upon long-standing use. Type of tradition European Specified strength Indications 1, 2 and 3 Single dose Children between 4 to 10 years of age Semi-solid preparations 2-10 % Hydroethanolic preparations 2-4 % Children between 10 to 12 years of age, adolescents between 12 to 16 years of age Semi-solid preparations 5-15 % Hydroethanolic preparations 3-6 % Adolescents over 16 years of age, adults Semi-solid and oily preparations 5-20 % In aqueous-ethanol preparations 5-10 % In nasal ointments 1-5 % essential oil. Specified posology Up to three times daily The use in children under 2 years of age is contraindicated (see “Contraindications”). The use is not recommended in children between 2 to 4 years of age (see “Special warnings and precautions for use”). Route of administration Cutaneous and transdermal. Duration of use or any restrictions on the duration of use Indication 1 Not to be used for more than 2 weeks. Indications 2 and 3 It is not recommended to use the medicinal product continuously for more than 3 months. If the symptoms persist during the use of the medicinal product, a doctor or a qualified health care practitioner should be consulted. Any other information necessary for the safe use Contraindications Children under 2 years of age, because menthol can induce reflex apnoea and laryngospasm. Children with history of seizures (febrile or not). Hypersensitivity to peppermint oil or menthol. Special warnings and precautions for use Eye contact with unwashed hands after the application of peppermint oil may potentially cause irritation. Peppermint oil should not be applied on broken or irritated skin. The use is not recommended in children between 2 to 4 years of age, as there is no sufficient experience available. Interactions with other medicinal products and other forms of interaction None reported. Pregnancy and lactation In the absence of sufficient data, the use during pregnancy and lactation is not recommended. Effects on ability to drive and use machines No studies on the effect on the ability to drive and use machines have been performed. Undesirable effects Hypersensitivity reactions such as skin rash, contact dermatitis, and eye irritation have been reported. These reactions are most of the time mild and transient. The frequency is not known. Irritation of the skin and mucosa of the nose is possible, after local application. The frequency is not known. If other adverse reactions not mentioned above occur, a doctor or a qualified health care practitioner should be consulted. Overdose No case of overdose has been reported.’

Other acts of the same type
Commission Implementing Decision (EU) 2026/2316 of 15 October 2026 on the recognition of the Roundtable on Sustainable Biomaterials (RSB) EU RED voluntary scheme for demonstrating compliance with the requirements for biofuels, bioliquids, biomass fuels, renewable fuels of non-biological origin and recycled carbon fuels set out in Directive (EU) 2018/2001 of the European Parliament and of the Council, and repealing Commission Implementing Decision (EU) 2022/607Council Decision (CFSP) 2026/2332 of 15 October 2026 amending Decision 2014/145/CFSP concerning restrictive measures in respect of actions undermining or threatening the territorial integrity, sovereignty and independence of UkraineCommission Implementing Decision (EU) 2026/2321 of 14 October 2026 amending Implementing Decision (EU) 2026/1108 concerning certain emergency measures relating to sheep pox and goat pox in Romania (notified under document C(2026) 7327)Political and Security Committee Decision (CFSP) 2026/2392 of 14 October 2026 extending the mandate of the Head of Mission of the European Union Advisory Mission in support of Security Sector Reform in Iraq (EUAM Iraq) (EUAM Iraq/2/2026)Council Decision of 13 October 2026 replacing a member of the Management Board of the European Centre for the Development of Vocational Training (Cedefop) for FranceCouncil Decision of 13 October 2026 replacing a full member of the Advisory Committee on Safety and Health at Work for CroatiaCouncil Decision of 13 October 2026 replacing a member of the Management Board of the European Agency for Safety and Health at Work for PortugalCouncil Decision of 13 October 2026 replacing an alternate member of the Advisory Committee on Safety and Health at Work for CroatiaCommission Implementing Decision (EU) 2026/2267 of 13 October 2026 establishing the format and frequency of data and the list of relevant raw materials to be reported by the Member States for the purposes of reporting on environmental data on industrial installations under Regulation (EU) 2024/1244 of the European Parliament and of the Council and repealing Commission Implementing Decision (EU) 2019/1741 (notified under document C(2026) 7610)Council Implementing Decision (CFSP) 2026/2312 of 13 October 2026 implementing Decision 2012/642/CFSP concerning restrictive measures in view of the situation in Belarus and the involvement of Belarus in the Russian aggression against UkraineCouncil Decision (CFSP) 2026/2317 of 13 October 2026 amending Decision 2010/638/CFSP concerning restrictive measures in view of the situation in GuineaPolitical and Security Committee Decision (CFSP) 2026/2320 of 13 October 2026 on the appointment of the Head of the Civilian Command and Support Cell of the European Union Security and Defence Initiative in support of West African countries of the Gulf of Guinea (EUSDI Gulf of Guinea) (EUSDI/2/2026)

Source: EUR-Lex (Publications Office of the EU), © European Union, reuse permitted under Commission Decision 2011/833/EU.

Contents

What to look at next